We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

APO:NYSEApollo Global Management, Inc. (New) Analysis

Data as of 2026-06-03 - not real-time

$128.76

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Apollo Global Management (APO) trades at $128.76, essentially inline with its DCF fair value of $129.17, suggesting a neutral price stance. However, the stock carries an eye‑popping trailing P/E of 81.5 versus an industry average of 16.6, while the forward P/E compresses to 12.1, indicating earnings are expected to improve. Technicals show a neutral trend with the 20‑day SMA just above price, a bearish MACD histogram, and decreasing volume, all pointing to limited upside in the near term.
The company faces material legal headwinds: multiple securities‑fraud class‑action notices warn investors of potential liability, adding reputational and financial risk. On the upside, Apollo announced a majority‑stake acquisition of Noble Environmental, a waste‑management firm, which could diversify earnings and support growth. Dividend sustainability is questionable given a payout ratio above 100% and modest profit margins.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish MACD and decreasing volume signal limited near‑term upside
  • Pending securities‑fraud lawsuit adds legal uncertainty
  • Current valuation appears neutral but trailing P/E remains extremely high

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Acquisition of Noble Environmental offers new growth avenues
  • Forward P/E of ~12 suggests earnings improvement
  • Strong cash position offsets high leverage

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Diversified alternative‑asset platform can generate stable cash flows
  • Resolution of legal matters could unlock shareholder value
  • Potential to reallocate capital from unsustainable dividend to reinvestment

Key Metrics & Analysis

Financial Health

Revenue Growth-9.20%
Profit Margin3.66%
P/E Ratio81.5
ROE8.49%
ROA0.71%
Debt/Equity101.27
P/B Ratio4.0
Op. Cash Flow$7.9B
Industry P/E16.6

Technical Analysis

TrendNeutral
RSI51.5
Support$126.08
Resistance$136.58
MA 20$130.80
MA 50$122.31
MA 200$128.95
MACDBearish
VolumeDecreasing
Fear & Greed Index93.27

Valuation

Fair Value$129.17
Target Price$150.25
Upside/Downside16.69%
GradeFair
TypeBlend
Dividend Yield1.75%

Risk Assessment

Beta1.31
Volatility28.98%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.